Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
6316325
Reference Type
Journal Article
Title
Management of giant retinal tears using transscleral diode laser retinopexy and short-term postoperative tamponade with perfluoro-n-octane
Author(s)
Bhardwaj, G; Connell, PP; Campbell, WG
Year
2020
Is Peer Reviewed?
1
Journal
Retina
ISSN:
0275-004X
EISSN:
1539-2864
Volume
40
Issue
3
Page Numbers
546-551
Language
English
PMID
30576303
DOI
10.1097/IAE.0000000000002424
Web of Science Id
WOS:000523731700018
Abstract
Purpose: To determine the results of pars plana vitrectomy for giant retinal tear detachments using transscleral diode laser retinopexy and short-term postoperative tamponade with perfluoro-n-octane (PFnO).
Methods: Twenty consecutive patients with fresh giant retinal tears were enrolled in a single-arm prospective study. One case was withdrawn for technical reasons. The remainder all underwent pars plana vitrectomy, PFnO injection, transscleral diode laser retinopexy to the edge of the giant retinal tear, and short-term postoperative heavy liquid tamponade. None of the cases had scleral buckling or lensectomy.
Results: Nineteen cases (18 male and 1 female) with a mean age of 41 years (range 10-69 years) were followed up for a period of 6 months. Postoperative tamponade with PFnO was maintained for a mean of 7.6 days (range 4-21 days), after which it was exchanged for sulfur hexafluoride (SF6), perfluoropropane (C3F8) gas, or balanced salt solution. Final reattachment rate was 100%, with 3 (15.7%) patients requiring additional surgery. Best-corrected visual acuity at final follow-up was 20/40 or better in 11 eyes (58%), between 20/60 and 20/200 in 7 (37%), and 20/400 in 1 (5%).
Conclusion: In this series of acute giant retinal tears, transscleral diode laser retinopexy together with the use of PFnO for short-term postoperative tamponade achieved excellent anatomical and visual results.
Tags
PFAS
•
Additional PFAS (formerly XAgency)
•
Expanded PFAS SEM (formerly PFAS 430)
Litsearch Update: November 2021
PubMed
Perfluorooctane
•
PFAS 150
Literature Search Update December 2021
PubMed
Perfluorooctane
•
PFAS Universe
Data Source
Web of Science
Pubmed
Perfluorotetradecahydrophenanthrene
Perflutren
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity